A phase II study of ramucirumab for advanced, pre-treated biliary cancers.

被引：2
|
作者：
Mizrahi, Jonathan
Javle, Milind M.
Xiao, Lianchun
Varadhachary, Gauri R.
Raghav, Kanwal Pratap Singh
Wolff, Robert A.
Shroff, Rachna T.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept GI Med Oncol, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.4081
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4081
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Ramucirumab plus pembrolizumab in previously treated advanced or metastatic biliary tract cancer: A multi-disease phase 1 study
    Hendrik-Tobias, Arkenau
    Johanna, Bendell
    Roy, Herbst
    Gu, Mi
    Jin, Jin
    Jessicca, Rege
    David, Ferry
    Ian, Chau
    ANNALS OF ONCOLOGY, 2017, 28
  • [42] A phase II study of nab-paclitaxel in combination with ramucirumab in patients with previously treated advanced gastric cancer
    Bando, Hideaki
    Shimodaira, Hideki
    Fujitani, Kazumasa
    Takashima, Atsuo
    Yamaguchi, Kensei
    Nakayama, Norisuke
    Takahashi, Takehiro
    Oki, Eiji
    Azuma, Mizutomo
    Nishina, Tomohiro
    Hironaka, Shuichi
    Komatsu, Yoshito
    Shitara, Kohei
    EUROPEAN JOURNAL OF CANCER, 2018, 91 : 86 - 91
  • [43] Phase I study of CT-2584 with cisplatin inpatients with advanced cancers.
    Skubitz, KM
    Warner, M
    Paradise, C
    Lau, DH
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3696S - 3696S
  • [44] Phase-1 study of isophosphoramide mustard (IPM)-lysine in advanced cancers.
    Gale, R.
    Van Vugt, A.
    Rosen, L.
    Chang, L.
    Lorusso, P.
    Valdivieso, M.
    Malburg, L.
    Struck, R.
    Morgan, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 525S - 525S
  • [45] Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in advanced cancers.
    Sen, Shiraj
    Piha-Paul, Sarina Anne
    Kato, Shumei
    Karp, Daniel D.
    Janku, Filip
    Fu, Siqing
    Naing, Aung
    Pant, Shubham
    Tsimberidou, Apostolia Maria
    Subbiah, Vivek
    Kurzrock, Razelle
    Meric-Bernstam, Funda
    Hong, David S.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [46] Phase I study of resminostat/S-1 combination in patients with pre-treated biliary tract or pancreatic cancer
    Morizane, C.
    Ohno, I.
    Ueno, H.
    Mitsunaga, S.
    Hashimoto, Y.
    Okusaka, T.
    Kondo, S.
    Sasaki, M.
    Sakamoto, Y.
    Takahashi, H.
    Hara, R.
    Kobayashi, S.
    Nakamura, O.
    Ikeda, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [47] Intravenous Topotecan in patients with advanced non-small cell lung cancer pre-treated with platinum and taxanes: Results of a phase II study
    Esteban, E.
    Crespo, G.
    Berros, J. P.
    Sanmamed, M.
    Muriel, C.
    Blay, P.
    Villanueva, N.
    Jimenez, P.
    Luque, M.
    Lacave, A. J.
    EJC SUPPLEMENTS, 2009, 7 (02): : 524 - 524
  • [48] AZD9291 in Pre-Treated T790M Positive Advanced NSCLC: AURA Study Phase II Extension Cohort
    Yang, James Chih-Hsin
    Ahn, Myung-Ju
    Ramalingam, Suresh S.
    Sequist, Lecia V.
    Novello, Silvia
    Su, Wu-Chou
    Hirashima, Tomonori
    Kim, Dong-Wan
    Lawrance, Rachael
    Cantarini, Mireille
    Ghiorghiu, Serban
    Jaenne, Pasi A.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S319 - S319
  • [49] AZD9291 in Pre-Treated T790M Positive Advanced NSCLC: AURA2 Phase II Study
    Mitsudomi, Tetsuya
    Tsai, Chun-Ming
    Shepherd, Frances
    Bazhenova, Lyudmila
    Lee, Jong Seok
    Chang, Gee-Chen
    Crino, Lucio
    Satouchi, Miyako
    Chu, Quincy
    Lawrance, Rachael
    Cantarini, Mireille
    Ghiorghiu, Serban
    Goss, Glenwood
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S320 - S320
  • [50] Phase I/II study to evaluate DLT, MTD and tolerability of bendamustine in pre-treated patients with advanced; Relapsed or refractory B-CLL.
    Arnaudov, G
    Lissitchkov, T
    Peytchev, D
    Ganeva, P
    Merkle, K
    BLOOD, 2003, 102 (11) : 356B - 356B
12345